+1-888-308-5802     
News Contact Us

United States emerge as a lucrative revenue pocket for vaccines market over 2019-2024

Author : Rahul Sankrityayan | Published Date : 2019-04-16 

Global Vaccines Market is set to exceed USD 65 billion by 2024; according to a new research report by Global Market Insights, Inc. Technological advances, rising demand for low cost products and widespread routine vaccination programmes in emerging economies will stimulate the business growth. Increasing demand for combined vaccines that offers immunization against several diseases, growing initiatives for production of low-cost vaccines will further boost the industry growth.
 
Growing adoption of cancer therapeutic vaccines, improved patient compliance along with mounting product pipeline will drive the business growth. Growing efforts to help avert adverse reactions and adoption of appropriate preventive screening methods will propel the business size.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2186
 
Growing demand for preventive vaccines, rising awareness coupled with mounting demand among the developing countries should boost the business revenue. Immunization currently prevents an estimated 2 to 3 million deaths every year. Furthermore, additional 1.5 million deaths could be evaded through improved global vaccination coverage. Increasing uptake of new and underused vaccines will prominently intensify its global usage over the forecast years.

How the United States may emerge as a lucrative revenue pocket for vaccines market over 2017-2024

The United States has been deemed to be one of the most potentially remunerative regions for the growth of vaccines industry, given that the region is abound with the most sophisticated healthcare infrastructure and medical care personnel. Not to mention, the United States has a record of cancer, pneumococcal disease, Hepatitis B incidences, and the like, which has created a lucrative avenue for the development of vaccines market in the region. According to the National Foundation for Infectious Diseases (NFID), around 1 million of the U.S. adult populace are affected by pneumococcal pneumonia per year. 

An estimated 5% to 7% among them are expected to die of the disease, even as the death risk is said to be higher among patients beyond the age of 65. In response, vaccines market giants have already devised suitable preventive measures that can be administered to children, adults, and the elderly. However, surveys still indicate that not many in the U.S. have received a pneumococcal pneumonia, thereby paving the way for medical organizations to conduct awareness programs regarding the availability of the vaccine. In consequence, this would create an avenue for vaccines industry players to further develop and commercialize the vaccine to be used for the masses, thereby impelling U.S. vaccines market outlook.
 
It is prudent to mention that the U.S. Health & Human Services (HHS) has also been taking numerous initiatives to reduce the occurrence of infectious diseases by means of raising immunization rates, which would most certainly impact U.S. vaccines market share. Companies on the home turf have been vying with one another to manufacture innovative vaccines and obtain the much-revered FDA approval for the same. 

In fact, just recently, Dynavax Technologies Corp. declared that its HEPLISAV-B - Hepatitis B vaccine has been granted approval by the U.S. FDA to help prevent all the known types of Hepatitis B infection in adults. Driven by the robust efforts by medical companies, in conjunction with government initiatives for generating awareness regarding the significance of vaccination, U.S. held the largest share of the regional vaccines industry in 2016, and is expected to grow massively in the years to come.

Global vaccines market has been projected to experience a remarkable expansion in the years ahead. Driven by the escalating occurrence of potentially fatal diseases, companies partaking in vaccines market share have been bringing to fruition, a plethora of innovative technologies that may help prevent the masses from getting afflicted with dangerous ailments. As per estimates, vaccines industry size stood at a valuation of USD 32 billion in 2016, driven by the escalating demand for preventive vaccines worldwide. In recent times, the funding for vaccine-based R&D activities has also witnessed an inclined curve, which has led to the development of technologically advanced products and low-cost vaccines. 

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2186

Some of the companies operating in industry are Abbott, AstraZeneca, Astellas Pharma, Bristol-Myers Squibb, CSL, Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Novavax, Pfizer and Sanofi Pasteur. New product launches and expansion of existing product portfolio will mainly drive the business growth. Major industry participants will endeavor to fortify their market position by adopting these strategies.

About Author

Rahul Sankrityayan

Rahul Sankrityayan

Fortified with a post-graduate degree in Computer Applications, Rahul Sankrityan writes for Fractovia, where he pens down news and articles spanning across segments of technology industry that excite him on a day-to-day basis. Rahul comes with a rich experience in technical field as well as writing. He can be contacted at- [email protected] | https://twitter.com/sankritsays

Related News

Gourmet Salt Market driven by culinary & preserving applications in food industry, Europe to emerge as strong regional contender

Published Date: 2019-04-19         Author: Rahul Sankrityayan

Gourmet salt market has undoubtedly embarked on a profitable path over the recent past years, with restaurateurs and chefs seeking to unveil its culinary potential. There has been a paradigm shift in the business model of the hospitality sector, where consumers are not only interested in the taste f... Read More

Rice protein market valuation hit USD 115 million by 2024, Europe to majorly influence the regional landscape

Published Date: 2019-04-19         Author: Rahul Sankrityayan

Rice protein market is extensively characterized by novel product launches and lucrative mergers & acquisitions by major corporations. For instance, in August 2017, Bounce, a leading healthy snack making firm based in Australia, has introduced a new kind of vegetarian & plant-based protein p... Read More

Brewing Enzymes Market Trends Analysis Growth Forecast Insights 2024

Published Date: 2019-04-19         Author: Rahul Sankrityayan

Brewing enzymes market has lately been on an explosive growth path with the rising popularity of beer consumption. While the drinking of beer has held a strong place in the culture of various European and North American nations, the rising levels of disposable incomes in emerging nations and the gro... Read More

© 2019 Fractovia. All Rights Reserved